Roche Rejoins ABPI After Long Absence To Help Forum Address Brexit
Executive Summary
Roche's decision to return to the UK industry body the ABPI reflects the Swiss company’s considerable commercial interests in Britain and the need for drug makers operating there to work more closely together as the Brexit process begins.